US FDA Turns To Temporary Enforcement Discretion For Boosting Infant Formula Supply
Agency Also Allows Abbott Facility To Restart Production Under Consent Decree
FDA launches temporary enforcement discretion on infant formula product to help increase supply in US on same day consent decree announced to allow Abbott to restart production at facility closed since February, prompting ongoing formula shortage.
